Hereditary dyslipidaemias and combined risk factors in children with a family history of premature coronary artery disease

Archives of Disease in Childhood

Volumn 82, Issue 4, 2000, Pages 292-296

  Sveger, T ^a   Flodmark, C E ^a   Nordborg, K ^a   Nilsson Ehle, P ^a   Borgfors, N ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b National Health Service   (Sweden)

Author keywords

Coronary artery disease; Dyslipidaemia; Preventive cardiology

Indexed keywords

APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; APOLIPOPROTEIN; LIPOPROTEIN;

ARTICLE; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; FAMILIAL DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILIAL HYPERLIPEMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SCHOOL CHILD; BLOOD; CHILD; GENETICS; HYPERLIPIDEMIA; MIDDLE AGED; PEDIGREE;

APOLIPOPROTEINS; CHILD; CORONARY DISEASE; FEMALE; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEINS; MALE; MIDDLE AGED; PEDIGREE; QUESTIONNAIRES; RISK FACTORS;

EID: 0033622117     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.82.4.292     Document Type: Article

References (30)

1. 1 Tracy RE, Weman WP, Wattingney WA, Srinivasan SR, Strong JP, Barenson GS. Histologic features of atherosclerosis and hypertension from autopsies of young individuals in a defined geographic population: the Bogalusa Heart Study. Atherosclerosis 1995;116:163-79.
2. 2 Raitakari OT, Leino M, Räikkönen K, et al. Clustering of risk habits in young adults: the cardiovascular risk in young Finns study. Am J Epidemiol 1995;142:36-44.
3. 3 Schaefer EJ, Lamon-Fava S, Ausman LM, et al. Individual variability in lipoprotein cholesterol response to National Cholesterol Education Program Step 2 diets. Am J Clin Nutr 1997;65:823-30.
4. 4 Raitakari OT, Porkka KVK, Taimela S, Telema R, Räsänen L, Viikari JSA. Effects of persistent physical activity and inactivity on coronary risk factors in children and young adults. The cardiovascular risk in young Finns study. Am J Epidemiol 1994;140:195-205.
5. 5 Flodmark CE, Ohlsson T, Rydén O, Sveger T. Prevention of progression to severe obesity in a group of obese schoolchildren treated with family therapy. Pediatrics 1993; 91:880-4.
6. 6 Genest JJ, Martin-Munley SS, Mc Namara JR, et al. Familial lipoprotein disorders in patients with premature CAD. Circulation 1992;85:2025-33.
7. 7 Sveger T, Fex G, Borgfors N. Hyperlipidemia in school children with family histories of premature coronary heart disease. Acta Paediatr Scand 1987;76:311-15.
8. 8 Nilsson JE, Lanke J, Nilsson-Ehle P, Tryding N, Scherstén B. Reference intervals and decision limits for plasma lipids and lipoproteins: a practical evaluation of current recommendations. Scand J Clin Lab Invest 1994;54:137-46.
9. 9 Davies H. Atherogenesis and the coronary arteries in childhood. Int J Cardiol 1990;28:283-92.
10. 10 American Academy of Pediatrics National Cholesterol Education Program: report of expert panel on blood cholesterol levels in children and adolescents. Pediatrics 1992;89:525-84.
11. 11 European Atherosclerosis Society. International Task Force for Prevention of Coronary Heart Disease: scientific background and new clinical guidelines. Nutr Metab Cardiovasc Dis 1992;2:113-56.
12. 12 Bao W, Srinivasan SR, Wattigney WA, Berenson GS. The relation of parental cardiovascular disease to risk factors in children and young adults. The Bogalusa Heart Study. Circulation 1995;91:365-71.
13. 13 Diller PM, Huster GA, Leach AD, Laskarzewski PM, Sprecher DL. Definition and application of the discretionary screening indicators according to the National Cholesterol Education Program for Children and Adolescents. J Pediatr 1995;126:345-52.
14. 14 Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,622 men. Lancet 1986;ii: 933-6.
15. 15 Newman T, Browner W, Hulley S. The case against childhood cholesterol screening. JAMA 1990;264:3039-43.
16. 16 LRC Program: The LRC Coronary Primary Prevention Trial Results, III: the relationship of reduction in incidence of CAD to cholesterol lowering. JAMA 1984; 251:365-74.
17. 17 McNeil TF, Thelin T, Aspegren-Jansson E, Sveger T, Harty B. Psychological factors in cost-benefit analysis of somatic prevention. Acta Paediatr Scand 1985;74:427-82.
18. 18 Goldstein JL, Schrott HG, Hazzard WR, Birman EL, Motulsky AG. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 1973;52:1544-68.
19. 19 Goldstein JL, Hobbs H, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease, Vol II, 7th ed. New York: McGraw-Hill, 1995:1981-2030.
20. 20 Kwiterovich PO, Frederickson DS, Levy RI. Familial hypercholesterolemia (one form of familial hyperlipoproteinemia): a study of its biochemical, genetic, and clinical presentation in childhood. J Clin Invest 1974;53:1237-49.
21. 21 Ode L, Tonstad S. The detection and management of dyslipidemia in children and adolescents. Acta Paediatr 1995;84:1213-15.
22. 22 Dixon LB, Shannon BM, Terchakovec AM, Bennett MJ, Coates PM, Cortier JA. Effects of family history of heart disease apolipoprotein E phenotype, and lipoprotein (a) on the response of children's plasma lipids to change in dietary iipids. Am J Clin Nutr 1977;66:1207-17.
23. 23 Cortner JA, Coates PM, Liacouras CA, Jarvik GP. Familial combined hyperlipidemia in children: clinical expression, metabolic defects, and management. J Pediatr 1993;123: 177-84.
24. 24 Kwiterovich PO Jr. Biochemical, clinical, genetic and metabolic studies of hyperapo-β-lipoproteinemia. J Inher Metab Dis 1988;11(suppl 1):57-73.
25. 25 Wissler RW, for the PDAY Research Group. An overview of quantitative influence of several risk factors or progression of atherosclerosis in young people in the United States. Am J Med Sci 1995;310:29-36.
26. 26 Raitakari OT, Porkka KVK, Rönnemaa T, Knip M, Uhari M, Viikari JSA. The role of insulin in clustering of serum lipids and blood pressure in children and adolescents: the cardiovascular risk in young Finns study. Diabetologica 1995;38:1024-50.
27. 27 Flodmark CE, Sveger T, Nilsson-Ehle P. Waist measurement correlates to a potentially atherogenic lipoprotein profile in obese school children. Acta Paediatr 1994;83:941-5.
28. 28 Terres W, Tatsis E, Pfalzer B, Beil U, Beisiegel U, Hamm CW. Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein (a). Circulation 1995;91:948-50.
29. 29 Maher VMG, Brown BG. Lipoprotein (a) and coronary heart disease. Curr Opin Lipidol 1995;6:229-35.
30. 30 Maher VMG, Brown BG, Marcovina SM, Hillger LA, Zhao X-Q, Albers JJ. Atherogenic effects of lipoprotein (a) in hyperlipidemic men with coronary disease: benefit of altering LDL-and HDL-cholesterol levels. JAMA 1995;274: 1771-4.